Literature DB >> 16273720

Management of neuropathic pain.

Katherine E Galluzzi1.   

Abstract

Pain may be the most common reason patients seek treatment from physicians. When persistent and unrelieved, pain can frustrate both the person suffering with this condition and the physician trying to alleviate it. Relief from chronic pain may be particularly difficult to achieve and fraught with misconceptions. Treatment usually requires trials of physical, pharmacologic, and surgical interventions to achieve resolution. In cases that remain insoluble, patients must accept partial relief and seek adaptive strategies. The source of persistent pain may be nociceptive or neuropathic. Both utilize the same nervous system pathways for transmission, but significant physiologic differences exist in the mechanism through which the body processes and resolves these painful stimuli. Nociceptive pain that results from a known or obvious source (eg, trauma, cancer metastasis, ischemia, arthritis) is often easy to identify. Neuropathic pain, however, may occur in the absence of an identifiable precipitating cause. Physicians must remain alert to differences in presentation and course of neuropathic pain syndromes, some of which may be subtle or unusual.

Entities:  

Mesh:

Year:  2005        PMID: 16273720

Source DB:  PubMed          Journal:  J Am Osteopath Assoc        ISSN: 0098-6151


  18 in total

Review 1.  Back Pain with Leg Pain.

Authors:  Simon Vulfsons; Negev Bar; Elon Eisenberg
Journal:  Curr Pain Headache Rep       Date:  2017-07

Review 2.  Therapeutic Advances in Diabetes, Autoimmune, and Neurological Diseases.

Authors:  Jinsha Liu; Joey Paolo Ting; Shams Al-Azzam; Yun Ding; Sepideh Afshar
Journal:  Int J Mol Sci       Date:  2021-03-10       Impact factor: 5.923

3.  Intra-brain microinjection of human mesenchymal stem cells decreases allodynia in neuropathic mice.

Authors:  Dario Siniscalco; Catia Giordano; Umberto Galderisi; Livio Luongo; Nicola Alessio; Giovanni Di Bernardo; Vito de Novellis; Francesco Rossi; Sabatino Maione
Journal:  Cell Mol Life Sci       Date:  2009-11-24       Impact factor: 9.261

4.  Long-lasting effects of human mesenchymal stem cell systemic administration on pain-like behaviors, cellular, and biomolecular modifications in neuropathic mice.

Authors:  Dario Siniscalco; Catia Giordano; Umberto Galderisi; Livio Luongo; Vito de Novellis; Francesco Rossi; Sabatino Maione
Journal:  Front Integr Neurosci       Date:  2011-12-01

5.  Burden of illness associated with peripheral and central neuropathic pain among adults seeking treatment in the United States: a patient-centered evaluation.

Authors:  Caroline Schaefer; Rachael Mann; Alesia Sadosky; Shoshana Daniel; Bruce Parsons; Edward Nieshoff; Michael Tuchman; Srinivas Nalamachu; Alan Anschel; Brett R Stacey
Journal:  Pain Med       Date:  2014-07-08       Impact factor: 3.750

6.  A preliminary report on stem cell therapy for neuropathic pain in humans.

Authors:  E Russell Vickers; Elisabeth Karsten; John Flood; Richard Lilischkis
Journal:  J Pain Res       Date:  2014-05-08       Impact factor: 3.133

7.  Phospholipase A2 Inhibitor-Loaded Phospholipid Micelles Abolish Neuropathic Pain.

Authors:  Sonia Kartha; Lesan Yan; Meagan E Ita; Ahmad Amirshaghaghi; Lijun Luo; Yulong Wei; Andrew Tsourkas; Beth A Winkelstein; Zhiliang Cheng
Journal:  ACS Nano       Date:  2020-06-04       Impact factor: 15.881

8.  Epidemiology of trigeminal neuralgia: an electronic population health data study in Korea.

Authors:  Cheol-Hyeong Lee; Ho-Yeon Jang; Hyung-Sun Won; Ja-Sook Kim; Yeon-Dong Kim
Journal:  Korean J Pain       Date:  2021-07-01

9.  Burden of illness associated with painful diabetic peripheral neuropathy among adults seeking treatment in the US: results from a retrospective chart review and cross-sectional survey.

Authors:  Alesia Sadosky; Caroline Schaefer; Rachael Mann; Felicia Bergstrom; Rebecca Baik; Bruce Parsons; Srinivas Nalamachu; Edward Nieshoff; Brett R Stacey; Alan Anschel; Michael Tuchman
Journal:  Diabetes Metab Syndr Obes       Date:  2013-02-08       Impact factor: 3.168

Review 10.  Update on pharmacotherapy guidelines for treatment of neuropathic pain.

Authors:  J Mark Wallace
Journal:  Curr Pain Headache Rep       Date:  2007-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.